50
In band
Moving averages
SMA 200$23.43-61.33%
Company profile
Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.
SectorHealthcare
IndustryBiotechnology
Market cap$486.62M
P/E ratioNone
EPS$-2.45
Beta0.722
Dividend yield0.00%
52-week high$40.37
52-week low$2.96
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 44
VRTX
Vertex Pharmaceuticals Inc
RSI 41
CRSP
CRISPR Therapeutics AG
RSI 55
IOVA
Iovance Biotherapeutics Inc
RSI 76
MRNA
Moderna Inc
RSI 63
VKTX
Viking Therapeutics Inc
RSI 31
SRPT
Sarepta Therapeutics Inc
RSI 50
EDIT
Editas Medicine Inc
RSI 43
NVAX
Novavax Inc
RSI 62
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 59
RSI alerts for CAPR
Get an email the moment Capricor Therapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 9:58 AM EDT